University of Wisconsin-Madison officials are lashing out at new recommendations from an influential federal panel that could dramatically weaken patent protection for the university’s genetic research.
Among other things, the panel recommended essentially exempting genetic tests for cancer and other diseases from patent protection – meaning that anyone could use genetic diagnostic research from UW-Madison or any university without obtaining licenses.